CapitaLand Integrated Commercial Trust
SGX:C38U
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CapitaLand Integrated Commercial Trust
SGX:C38U
|
SG |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Filo Mining Corp
TSX:FIL
|
CA |
|
O
|
Orion Office Reit Inc
NYSE:ONL
|
US |
|
Dave Inc
NASDAQ:DAVE
|
US |
|
Fleury SA
BOVESPA:FLRY3
|
BR |
|
W
|
Wal Mart de Mexico SAB de CV
SWB:4GNB
|
MX |
Wall Street
Price Targets
C38U Price Targets Summary
CapitaLand Integrated Commercial Trust
According to Wall Street analysts, the average 1-year price target for
C38U
is 2.66
with a low forecast of 2.32 and a high forecast of 3.1 .
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is C38U's stock price target?
Price Target
2.66
According to Wall Street analysts, the average 1-year price target for
C38U
is 2.66
with a low forecast of 2.32 and a high forecast of 3.1 .
What is CapitaLand Integrated Commercial Trust's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
CapitaLand Integrated Commercial Trust's revenue is
7%.
The projected
CAGR
for the next 3 years is
4%.
What is CapitaLand Integrated Commercial Trust's Operating Income forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
CapitaLand Integrated Commercial Trust's operating income is
8%.
The projected
CAGR
for the next 3 years is
5%.
What is CapitaLand Integrated Commercial Trust's Net Income forecast?
Projected CAGR
2%
For the last 14 years the
compound annual growth rate for
CapitaLand Integrated Commercial Trust's net income is
7%.
The projected
CAGR
for the next 3 years is
2%.
